Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATNM | ZTS | TAK | UTHR | NBIX |
| Company | Actinium Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.8700 | 198.23 | 14.82 | 345.46 | 121.30 |
| High | 1.9150 | 200.33 | 14.94 | 353.04 | 122.81 |
| Low | 1.8200 | 191.31 | 14.82 | 344.47 | 119.66 |
| Last | 1.8800 | 193.24 | 14.93 | 351.33 | 120.46 |
| Change | +0.1000 | -3.24 | +0.11 | +8.74 | +0.61 |
| % Change | +5.62% | -1.65% | +0.74% | +2.55% | +0.51% |
| Volume | 240,213 | 2,463,092 | 1,119,002 | 454,427 | 788,198 |
| 20-Day Average Volume | 367,321 | 1,745,475 | 1,599,820 | 386,116 | 1,169,130 |
| Previous Close | 1.7800 | 196.48 | 14.82 | 342.59 | 119.85 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8925 | 187.87 | 14.88 | 348.87 | 128.40 |
| 20-Day Raw Stochastic | 42.55% | 64.81% | 64.29% | 48.35% | 6.57% |
| 20-Day Relative Strength | 31.78% | 61.30% | 61.34% | 57.16% | 34.84% |
| Weighted Alpha | -48.67 | +12.87 | +0.43 | +66.28 | -3.56 |
| Today's Opinion | 100% Sell | 88% Buy | 88% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 88% Buy | 72% Buy | 88% Buy | 40% Sell |
| Last Month's Opinion | 88% Sell | 72% Buy | 56% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.08% since 09/12/24 | +1.33% since 09/12/24 | +0.74% since 09/12/24 | +3.00% since 09/12/24 | -0.68% since 09/12/24 |
| Low | 1.7500 on 09/16/24 | 190.13 on 09/13/24 | 14.66 on 09/13/24 | 337.52 on 09/13/24 | 119.37 on 09/18/24 |
| High | 2.0100 on 09/13/24 | 200.33 on 09/19/24 | 14.94 on 09/17/24 | 353.63 on 09/17/24 | 123.57 on 09/16/24 |
| 1-Month | |||||
| %Chg | -10.05% since 08/19/24 | +4.75% since 08/19/24 | +1.43% since 08/19/24 | +0.79% since 08/19/24 | -18.74% since 08/19/24 |
| Low | 1.6800 on 09/06/24 | 180.18 on 08/23/24 | 14.66 on 09/13/24 | 337.52 on 09/13/24 | 118.04 on 09/10/24 |
| High | 2.2800 on 08/20/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 154.87 on 08/23/24 |
| 3-Month | |||||
| %Chg | -76.11% since 06/18/24 | +13.90% since 06/18/24 | +17.84% since 06/18/24 | +14.80% since 06/18/24 | -7.95% since 06/18/24 |
| Low | 1.3300 on 08/05/24 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 302.71 on 06/20/24 | 118.04 on 09/10/24 |
| High | 8.6400 on 07/23/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 157.98 on 08/01/24 |
| 6-Month | |||||
| %Chg | -77.10% since 03/19/24 | +11.73% since 03/19/24 | +3.61% since 03/19/24 | +46.75% since 03/19/24 | -14.49% since 03/19/24 |
| Low | 1.3300 on 08/05/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 221.53 on 04/01/24 | 118.04 on 09/10/24 |
| High | 10.2400 on 05/14/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 157.98 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 53,014 | 89,652,840 | 46,902,880 | 15,195,919 | 12,061,345 |
| Shares Outstanding, K | 29,783 | 456,295 | 3,164,837 | 44,356 | 100,637 |
| Annual Sales | 80,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -48,820,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 0 | 2,361,000,000 | 7,731,140,000 | 714,900,000 | 590,200,000 |
| Last Quarter Net Income | -8,670,000 | 624,000,000 | 609,590,000 | 278,100,000 | 65,000,000 |
| 60-Month Beta | 0.14 | 0.88 | 0.54 | 0.57 | 0.37 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 08/05/24 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 5.85 on 07/31/24 | 0.63 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 11/07/24 | 10/24/24 | 11/06/24 | 10/29/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 35.33 | 9.46 | 15.86 | 36.95 |